Total Funding
66
48
Total FundingDebt Financing raised
Growth Score 66 in past quarter
-3 pts
Heat Score 48 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
23211
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications.
- Hank Jibaja: Chief Information Officer
- Lou Kennedy: Owner
About the Company
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies, and mail-order pharmacies.
It was founded in 1937 and headquartered in Florida, New York.
Women Founded
